| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 50.90B | 50.59B | 52.06B | 50.54B | 47.97B | 47.94B |
| Gross Profit | 13.57B | 13.32B | 13.23B | 12.01B | 11.35B | 11.68B |
| EBITDA | 4.36B | 3.56B | 4.30B | 4.03B | 3.96B | 4.41B |
| Net Income | 3.38B | 3.27B | 3.10B | 2.47B | 2.09B | 2.48B |
Balance Sheet | ||||||
| Total Assets | 49.16B | 53.72B | 54.73B | 48.53B | 44.21B | 47.26B |
| Cash, Cash Equivalents and Short-Term Investments | 13.91B | 16.23B | 13.78B | 11.04B | 13.79B | 11.63B |
| Total Debt | 1.77B | 2.93B | 2.07B | 2.64B | 2.96B | 3.03B |
| Total Liabilities | 13.85B | 17.90B | 17.02B | 16.18B | 14.91B | 15.86B |
| Stockholders Equity | 34.86B | 35.23B | 37.37B | 31.94B | 28.62B | 30.77B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.35B | 5.71B | 174.00M | 2.53B | 3.09B |
| Operating Cash Flow | 0.00 | 1.56B | 5.85B | 658.00M | 2.63B | 3.25B |
| Investing Cash Flow | 0.00 | -1.36B | -1.34B | 1.18B | -596.00M | 179.00M |
| Financing Cash Flow | 0.00 | -1.19B | -2.98B | -2.07B | -1.71B | -2.93B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥69.67B | 18.88 | 17.96% | 1.83% | 13.23% | 16.07% | |
77 Outperform | ¥85.68B | 19.07 | ― | 2.32% | 5.09% | 26.12% | |
76 Outperform | ¥149.67B | 14.81 | ― | 2.30% | 13.82% | 37.07% | |
67 Neutral | ¥143.24B | 11.58 | ― | 2.22% | 9.29% | 1.18% | |
66 Neutral | ¥164.99B | 15.99 | 18.89% | 2.78% | 11.90% | 60.66% | |
65 Neutral | ¥31.25B | 10.75 | 10.34% | 4.82% | -3.03% | 38.83% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |